iparomlimab
Drug timelines are a Plus or Pro feature.
75 regulatory and trial events tracked for iparomlimab, covering 2025-02-17 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study [Phase 2]